Simple, cheap, non toxic and ignored
Professor of Oncology, Angus Dalgleish gives vital information on a repurposed drug he uses for his cancer patients, given at a very low dose. This is Low Dose Naltrexone.
Check out the LDN trust website for much more, https://ldnresearchtrust.org
Naltrexone at low doses (LDN) and its relevance to cancer therapy
https://openaccess.sgul.ac.uk/id/epri...
Naltrexone was designed to inhibit opioid receptors without activating them and hence used to block the stimulatory effects of morphine and heroin. It was noted that in certain patients being treated with naltrexone for an opioid addiction many reported significant secondary benefit when being weaned off naltrexone. This group of patients had chronic inflammatory and autoimmune conditions and reported improvements whilst using the lower dosages of naltrexone. There have also been recent anecdotal reports of cancer resolution following the use of low doses of naltrexone (LDN). However, the mechanism of action is unclear.
Areas covered
We review three mechanisms through which LDN can influence cancer progression; namely, (a) antagonism of receptors to which LDN binds, which include toll-like receptors 7–9 that lead to IL-6 suppression b) modulation of immune function in patients; and c) direct inhibition of signaling pathways involved in cancer cell control, including the priming of pro-apoptotic pathways.
Expert opinion
Considering the increase in the number of anecdotal reports of activity, there will likely be a bigger drive toward using LDN in the oncological setting. These reports support clinical trials of LDN in cancer, especially when given in combination with certain chemotherapy.
https://ldnresearchtrust.org/angus-da...
Major clinical evidence on the use of low-dose naltrexone in the treatment of cancer: a systematic review
https://www.researchgate.net/publicat...
https://www.tandfonline.com/doi/full/...
:00 🍏 Discussion on Simple, Non-Toxic Health Solutions
The conversation begins with highlighting the neglect of simple, cheap, and non-toxic health solutions like iodine and vitamin D.
Emphasis is placed on differences in health outcomes between countries that consume iodine-rich foods, like seaweed, and those that do not, such as the US and UK, where breast cancer rates are higher.
05:00 💊 Frustration with Pharmacy Practices and Medication Access
The speakers express frustration over pharmacists' lack of knowledge regarding iodine and other non-toxic medications.
Experiences in pharmacies reveal a broader issue of doctors and patients being denied access to potentially beneficial treatments.
10:00 📉 Barriers in Medical Practice and Prescribing Authority
Discussion on the limitations imposed on medical professionals, preventing them from applying their knowledge to help patients fully.
Anecdotes highlight instances where doctors are unable to prescribe effective treatments, leading to a bureaucratic environment stifling innovation.
14:00 🌍 The Impact of Current Medical Education on Practice
A critique of contemporary medical education emphasizes its focus on guidelines over creative medical thinking.
Medical students are discouraged from expanding their understanding, which harms their ability to think critically and adapt medicine to patient needs.
18:00 🔄 Historical Insight into Treatment Innovations
The speaker reflects on the freedom and creativity that past medical practices allowed compared to current restrictions on innovative treatments.
An inspiring case of repurposing chemotherapy to address a severe arthritis condition showcases the potential benefits of adaptive medical practices.
20:00 💡 Low Dose Naltrexone and Emerging Treatments
The discussion shifts to the potential of Low Dose Naltrexone (LDN) as a promising treatment option that remains under-recognized in the medical community.
Insights on how LDN operates and its positive anecdotal effects highlight the need for more awareness and research into alternative treatment methods.
https://www.youtube.com/@Campbellteaching
https://drjohncampbell.co.uk
https://www.patreon.com/JohnCampbell2